Milestone Event Milestone Payment. [***] [***]
Milestone Event Milestone Payment. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of [**]
Milestone Event Milestone Payment. 6 First time Annual Net Sales of all Products exceed $[***] $[***]
Milestone Event Milestone Payment. The first time in which worldwide, aggregate Net Sales in a calendar year of [**] Engineered T-Cell Products exceeds $[**] [**]
Milestone Event Milestone Payment. Development Milestone Sales Milestones
Milestone Event Milestone Payment. First dosing of a subject in a Phase I Study of a Licensed Product $10,000,000 [**] [**] [**] [**] [**] [**] [**] [**]
Milestone Event Milestone Payment. Initiation of first GLP Toxicology Study of a Product under the applicable Post-Effective Date Program [*]
Milestone Event Milestone Payment. First Commercial Sale of a Product under the Initial Program [*] Worldwide Net Sales of Products under the Initial Program exceed [*] in a calendar year [*] Worldwide Net Sales of Products under the Initial Program exceed [*] in a calendar year [*] Worldwide Net Sales of Products under the Initial Program exceed [*] in a calendar year [*]
Milestone Event Milestone Payment. Initiation of first Phase 2 Clinical Trial of a Product under the applicable Post-Effective Date Program [*] Initiation of first Phase 3 Clinical Trial of a Product under the applicable Post-Effective Date Program [*]
